Over the last 12 months, Co-Diagnostics insiders reported no purchases and 3 sales totaling $19K across SEC Form 4 filings.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| May 23, 2026 | Egan Dwight HChief Executive Officer · O·D | ▽ Sale to issuer | 1,633 | $5.07 | $8K | -5.5% | — |
| May 23, 2026 | Brown Brian LeeChief Financial Officer · O | ▽ Sale to issuer | 1,350 | $5.07 | $7K | -5.7% | — |
| May 23, 2026 | Abbott Richard DavidPresident · O | ▽ Sale to issuer | 680 | $5.07 | $3K | -16.6% | — |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CODX feed.